{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:54:14Z","timestamp":1792457654284,"version":"4.5.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bjanaesthesia.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["British Journal of Anaesthesia"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.bja.2025.08.065","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T12:23:49Z","timestamp":1762345429000},"page":"534-541","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Ecarin-based coagulation monitoring of argatroban in patients with heparin-induced thrombocytopenia: a prospective observational study"],"prefix":"10.1016","volume":"136","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-8518-3055","authenticated-orcid":false,"given":"Arno","family":"Schiferer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5464-443X","authenticated-orcid":false,"given":"Christine","family":"Schl\u00f6mmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0559-834X","authenticated-orcid":false,"given":"Georg","family":"Scheriau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2987-8490","authenticated-orcid":false,"given":"Daniela","family":"Boryshchuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias L.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6394-7044","authenticated-orcid":false,"given":"Sebastian","family":"Benque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6896-7854","authenticated-orcid":false,"given":"Caroline","family":"Holaubek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7775-3279","authenticated-orcid":false,"given":"Pedro","family":"Wendel-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2522-2166","authenticated-orcid":false,"given":"Barbara","family":"Steinlechner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bja.2025.08.065_bib1","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1309\/AJCPGTCEX7K4GXQO","article-title":"Comparison of the aPTT with alternative tests for monitoring direct thrombin inhibitors in patient samples","volume":"141","author":"Lind","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.bja.2025.08.065_bib2","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1160\/TH16-06-0468","article-title":"Monitoring anticoagulation with argatroban in critically ill patients: activated partial thromboplastin time versus diluted thrombin time","volume":"116","author":"Keyl","year":"2016","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.bja.2025.08.065_bib3","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s11239-019-01961-3","article-title":"Evaluation of intravenous direct thrombin inhibitor monitoring tests: correlation with plasma concentrations and clinical outcomes in hospitalized patients","volume":"49","author":"Beyer","year":"2020","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.bja.2025.08.065_bib4","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12871-018-0475-y","article-title":"Monitoring of argatroban and lepirudin anticoagulation in critically ill patients by conventional laboratory parameters and rotational thromboelastometry - a prospectively controlled randomized double-blind clinical trial","volume":"18","author":"Beiderlinden","year":"2018","journal-title":"BMC Anesthesiol"},{"key":"10.1016\/j.bja.2025.08.065_bib5","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000081506","article-title":"Ecarin chromogenic assay--a new method for quantitative determination of direct thrombin inhibitors like hirudin","volume":"33","author":"Lange","year":"2003","journal-title":"Pathophysiol Haemost Thromb"},{"key":"10.1016\/j.bja.2025.08.065_bib6","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1055\/s-0036-1597297","article-title":"Laboratory monitoring of parenteral direct thrombin inhibitors","volume":"43","author":"Van Cott","year":"2017","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.bja.2025.08.065_bib7","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/ALN.0000000000004787","article-title":"Monitoring of argatroban in critically ill patients: a prospective study comparing activated partial thromboplastin time, point-of-care viscoelastic testing with ecarin clotting time and diluted thrombin time to mass spectrometry","volume":"140","author":"Heubner","year":"2024","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2025.08.065_bib8","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.thromres.2008.02.013","article-title":"Comparison of the ecarin chromogenic assay and different aPTT assays for the measurement of argatroban concentrations in plasma from healthy individuals and from coagulation factor deficient patients","volume":"123","author":"Siegmund","year":"2008","journal-title":"Thromb Res"},{"key":"10.1016\/j.bja.2025.08.065_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-81396-w","article-title":"Detection of enoxaparin and argatroban by use of the novel viscoelastic coagulometer ClotPro","volume":"14","author":"Gratz","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.bja.2025.08.065_bib10","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s00508-013-0327-1","article-title":"Ecarin modified rotational thrombelastometry: a point-of-care applicable alternative to monitor the direct thrombin inhibitor argatroban","volume":"125","author":"Schaden","year":"2013","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.bja.2025.08.065_bib11","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC Guidelines for the management of acute coronary syndromes: developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC)","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.bja.2025.08.065_bib12","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1111\/jth.14929","article-title":"Scientific and Standardization Committee communication: clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19","volume":"18","author":"Spyropoulos","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.bja.2025.08.065_bib13","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/bjh.19180","article-title":"Diagnosis and management of heparin-induced thrombocytopenia: third edition","volume":"204","author":"Arachchillage","year":"2024","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bja.2025.08.065_bib14","doi-asserted-by":"crossref","first-page":"e526","DOI":"10.1097\/CCM.0000000000005441","article-title":"Intracranial hemorrhages on extracorporeal membrane oxygenation: differences between COVID-19 and other viral acute respiratory distress syndrome","volume":"50","author":"Seeliger","year":"2022","journal-title":"Crit Care Med"},{"key":"10.1016\/j.bja.2025.08.065_bib15","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1056\/NEJM197208172870703","article-title":"A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time","volume":"287","author":"Basu","year":"1972","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bja.2025.08.065_bib16","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.healun.2016.09.010","article-title":"Coagulation factor abnormalities related to discordance between anti-factor Xa and activated partial thromboplastin time in patients supported with continuous-flow left ventricular assist devices","volume":"35","author":"Adatya","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.bja.2025.08.065_bib17","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/ijlh.12109","article-title":"Determination of APTT factor sensitivity--the misguiding guideline","volume":"35","author":"Lawrie","year":"2013","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.bja.2025.08.065_bib18","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/labmed\/lmx050","article-title":"Coagulation testing in the core laboratory","volume":"48","author":"Winter","year":"2017","journal-title":"Lab Med"},{"key":"10.1016\/j.bja.2025.08.065_bib19","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1007\/s11239-019-01879-w","article-title":"Influence of factor XII deficiency on activated partial thromboplastin time (aPTT) in critically ill patients","volume":"48","author":"Bachler","year":"2019","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.bja.2025.08.065_bib20","doi-asserted-by":"crossref","first-page":"e1206","DOI":"10.1097\/CCM.0000000000005179","article-title":"Prevalence and clinical impact of reduced coagulation factor XII activity in patients receiving extracorporeal membrane oxygenation","volume":"49","author":"Buchtele","year":"2021","journal-title":"Crit Care Med"},{"key":"10.1016\/j.bja.2025.08.065_bib21","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/MAT.0000000000002085","article-title":"Prevalence of FXII-deficiency and its relevance to monitoring anticoagulation in adults receiving extracorporeal membrane oxygenation","volume":"70","author":"Brock","year":"2024","journal-title":"ASAIO J"}],"container-title":["British Journal of Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091225007093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091225007093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T16:41:39Z","timestamp":1779813699000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007091225007093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0007091225007093"],"URL":"https:\/\/doi.org\/10.1016\/j.bja.2025.08.065","relation":{},"ISSN":["0007-0912"],"issn-type":[{"value":"0007-0912","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ecarin-based coagulation monitoring of argatroban in patients with heparin-induced thrombocytopenia: a prospective observational study","name":"articletitle","label":"Article Title"},{"value":"British Journal of Anaesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bja.2025.08.065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 British Journal of Anaesthesia. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}